Limitations and opportunities in the pharmacotherapy of ciliopathies


Ciliopathies are a family of rather diverse conditions, which have been grouped based on the finding of altered or dysfunctional cilia, potentially motile, small cellular antennae extending from the surface of postmitotic cells. Cilia-related disorders include embryonically arising conditions such as Joubert, Usher or Kartagener syndrome, but also afflictions with a postnatal or even adult onset phenotype, i.e. autosomal dominant polycystic kidney disease. The majority of ciliopathies are syndromic rather than affecting only a single organ due to cilia being found on almost any cell in the human body. Overall ciliopathies are considered rare diseases. Despite that, pharmacological research and the strive to help these patients has led to enormous therapeutic advances in the last decade. In this review we discuss new treatment options for certain ciliopathies, give an outlook on promising future therapeutic strategies, but also highlight the limitations in the development of therapeutic approaches of ciliopathies. Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Authors Duong Phu M, Bross S, Burkhalter MD, Philipp M
Journal Pharmacology & therapeutics
Publication Date 2021 Sep;225:107841
PubMed 33771583
DOI 10.1016/j.pharmthera.2021.107841

Research Projects

Cell Lines